The Online Investor
Stock Buybacks
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Stock Buybacks

By The Online Investor Staff, updated Mon., Feb. 8, 7:07 AM

Slide #2. Edwards Lifesciences Corporation

Company: Edwards Lifesciences Corporation (NYSE:EW)
$Amount Authorized: $750,000,000
Buyback Details: Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced today that it has entered into an accelerated share repurchase (ASR) agreement with Morgan Stanley & Co. LLC to repurchase $325 million of Edwards' common stock. This repurchase is part of the Company's previously authorized program to repurchase up to $750 million of the Company's common stock.

Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. Co.'s products and technologies are categorized into three areas: Transcatheter Heart Valve Therapy, which includes technologies designed to treat heart valve disease using catheter-based approaches for certain patients deemed at high risk for traditional open-heart surgery; Surgical Heart Valve Therapy, which provides heart valve therapy and a manufacturer of heart valves and repair products; and Critical Care, which provides hemodynamic monitoring systems used to measure a patient's heart function in surgical and intensive care settings.

Edwards Lifesciences SEC Filing Email Alerts Service

Open the EW Page at The Online Investor »

Company Name:  Edwards Lifesciences Corp
Stock buyback:  EW buyback
Sector:  Medical Instruments & Supplies
Number of ETFs Holding EW:  75
Total Market Value Held by ETFs:  $760.76M
Total Market Capitalization:  $17.97B
% of Market Cap. Held by ETFs:  4.23%

Open the EW Page at The Online Investor (in a new window) »

February 8, 2016    7:07 AM Eastern
Quotes delayed 20 minutes

Strong Buy (3.58 out of 4)
69th percentile
(ranked higher than approx. 69% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Buybacks | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.